Home › Urothelial (Transitional Cell) Carcinoma › Louisiana › Baton Rouge
Urothelial (Transitional Cell) Carcinoma clinical trials in Baton Rouge, LA
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Baton Rouge (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
RecruitingPhase 3
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- Mary Bird Perkins Cancer Center, Baton Rouge
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
Other studies in Baton Rouge
- Obesity15 studies
- Overweight10 studies
- Non-Small Cell Lung Cancer10 studies
- Metastatic Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Lung Cancer8 studies
- Colorectal Cancer8 studies
- Breast Cancer7 studies
- Bladder Cancer6 studies
- Chronic Lymphocytic Leukemia5 studies
- Prostate Cancer5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.